Amir Mushtaq Parray

Amir Mushtaq Parray

Auto-generated profile, based on publicly available information

Amir Mushtaq Parray

BLK Max Super Speciality Hospital, New Delhi, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2021 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MGMahesh Goel
Mahesh Goel
AGAmit M. Gupta
Amit M. Gupta
SPShraddha Patkar
Shraddha Patkar
APAmir M. Parray
Amir M. Parray
NSNitin Shetty
Nitin Shetty
SMShaesta Mehta
Shaesta Mehta

1 March 2021 in Surgery in Practice and Science
Verified
Journal Article
Open access
APAmir Parray
Amir Parray
VGVikas Gupta
Vikas Gupta
VCVikram A. Chaudhari
Vikram A. Chaudhari
SSShailesh V. Shrikhande
Shailesh V. Shrikhande
Manish BhandareManish Bhandare
Manish Bhandare

14 December 2016 in Indian Journal of Surgery
Verified
Journal Article
Closed access
PDF file
APAmir Mushtaq Parray
Amir Mushtaq Parray
PMPeter Mwendwa
Peter Mwendwa
SMSiddharth Mehrotra
Siddharth Mehrotra
VMVivek Mangla
Vivek Mangla
SLShailendra Lalwani
Shailendra Lalwani
SNSamiran Nundy
Samiran Nundy

11 January 2021 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
SPShraddha Patkar
Shraddha Patkar
DNDevayani Niyogi
Devayani Niyogi
APAmir Parray
Amir Parray
MGMahesh Goel
Mahesh Goel

22 January 2026 in Annals of Surgery
Verified
Journal Article
Closed access
APAmir M. Parray
Amir M. Parray
NSNiket Shah
Niket Shah
SSSohan Lal Solanki
Sohan Lal Solanki
VAVandana Agarwal
Vandana Agarwal
NSNitin Sudhakar Shetty
Nitin Sudhakar Shetty
SSShailesh V. Shrikhande
Shailesh V. Shrikhande
Objective: To evaluate the T-MOD PD (Timing–Mechanism–Opportunity–Disease) framework for classifying mortality after pancreatoduodenectomy (PD) , focusing on preventability and rescue opportunities. Background: Pancreatoduodenectomy mortality (2–10%) is reported as binary endpoints, obscuring distinctions between surgery-related and systemic causes and limiting targeted quality improvement. Methods: Retrospective analysis of 1,727 consecutive PDs (2014–2024) at a high-volume centre. All 58 deaths (3.4%) were independently adjudicated across four axes: Timing (T1–T3), Mechanism (M1–M3), Opportunity (O1–O4), and Disease (D1–D3). Deaths were categorized as surgery-attributable potentially preventable (SAPM), surgery-attributable non-preventable (SANPM), or non-surgery-attributable mortality (NSAM). Results: Striking phenotypic clustering emerged: 38% of deaths (22/58) converged in T1M1O1D1 (early, surgery-related, strategically modifiable, resectable disease), with 19% (11/58) in T2M1O1D1. Together, these postoperative pancreatic fistula (POPF)-driven phenotypes accounted for 57% of mortality. Domain analysis revealed 66% early deaths (T1), 74% surgery-related mechanisms (M1), and critically, 72% potentially modifiable opportunities (O1: 72%; O2: 22%; O3: 2%; O4: 3%). Overall, 74% were classified as SAPM. Timeline reconstruction identified median 72-hour delays in recognition and escalation despite warning signs at postoperative day 5–6, with 22-day median interval from clinically relevant POPF diagnosis to death, suggesting 35–40% preventability in the dominant phenotype. Perfect interobserver agreement was achieved (κ=1.0). Conclusions: T-MOD PD provides reproducible mortality phenotyping revealing 72% of deaths are potentially modifiable, with dominant phenotypes sharing POPF pathways and identifiable rescue delays, enabling phenotype-specific quality improvement.

14 November 2023 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
APAmir M. Parray
Amir M. Parray
ASAnoop Singh
Anoop Singh
RVRavindra Vats
Ravindra Vats
MRMohammad Reyaz
Mohammad Reyaz
DGDeep Goel
Deep Goel